Overview
HealthEquity, Inc., based in the United States, operates predominantly within the health care sector, specifically focusing on technology-driven services that facilitate health savings accounts (HSAs) and other health financial services. Since its inception, the company has expanded its offerings to include reimbursement accounts such as FSAs, HRAs, as well as VEBA, and commuter benefits. A key project for HealthEquity involves integrating technology to simplify the management and accessibility of health accounts for both employers and account holders, emphasizing user-friendly platforms and 24/7 customer service. The company has also been actively working on partnerships and acquisitions to broaden its service capabilities and market reach, thereby consolidating its position as a leader in health account solutions in the U.S.
Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for HealthEquity, Inc. as of July 31, 2025 is 1,268.93 MM.
- The operating income for HealthEquity, Inc. as of July 31, 2025 is 273.62 MM.
- The net income for HealthEquity, Inc. as of July 31, 2025 is 145.84 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-07-31 | 1,268.93 | 273.62 | 145.84 |
2025-04-30 | 1,243.02 | 243.45 | 121.81 |
2025-01-31 | 1,199.77 | 202.87 | 96.70 |
2024-10-31 | 1,150.34 | 199.71 | 96.70 |
2024-07-31 | 1,099.13 | 179.19 | 105.67 |
2024-04-30 | 1,042.75 | 145.27 | 80.43 |
2024-01-31 | 999.59 | 128.13 | 55.71 |
2023-10-31 | 971.04 | 105.30 | 29.14 |
2023-07-31 | 937.91 | 83.80 | 12.82 |
2023-04-30 | 900.50 | 62.29 | -8.41 |
2023-01-31 | 861.75 | 37.65 | -26.14 |
2022-10-31 | 831.20 | 18.46 | -58.75 |
2022-07-31 | 795.07 | 19.29 | -62.15 |
2022-04-30 | 778.03 | 29.51 | -55.31 |
2022-01-31 | 756.56 | 40.57 | -44.29 |
2021-10-31 | 741.43 | 54.51 | -6.10 |
2021-07-31 | 740.83 | 61.33 | 0.72 |
2021-04-30 | 727.76 | 65.22 | 4.39 |
2021-01-31 | 733.57 | 80.00 | 8.83 |
2020-10-31 | 746.60 | 106.84 | 3.28 |
2020-07-31 |
Income Statement: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-07-31 | ||
2025-04-30 | 1.40 | 1.37 |
2025-01-31 | 1.11 | 1.09 |
2024-10-31 | 1.12 | 1.09 |
2024-07-31 | 1.22 | 1.20 |
2024-04-30 | 0.94 | 0.92 |
2024-01-31 | 0.65 | 0.64 |
2023-10-31 | 0.34 | 0.34 |
2023-07-31 | 0.15 | 0.15 |
2023-04-30 | -0.10 | -0.10 |
2023-01-31 | -0.31 | -0.31 |
2022-10-31 | -0.70 | -0.70 |
2022-07-31 | -0.74 | -0.74 |
2022-04-30 | -0.66 | -0.66 |
2022-01-31 | -0.53 | -0.53 |
2021-10-31 | -0.07 | -0.08 |
2021-07-31 | 0.01 | 0.01 |
2021-04-30 | 0.06 | 0.06 |
2021-01-31 | 0.12 | 0.12 |
2020-10-31 | 0.05 | 0.05 |
2020-07-31 | -0.28 | -0.28 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for HealthEquity, Inc. as of July 31, 2025 is 366.90 MM.
- The cash from investing activities for HealthEquity, Inc. as of July 31, 2025 is -53.74 MM.
- The cash from financing activities for HealthEquity, Inc. as of July 31, 2025 is -335.59 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-07-31 | 366.90 | -53.74 | -335.59 |
2025-04-30 | 339.17 | -251.65 | -50.85 |
2025-01-31 | 339.86 | -505.45 | 57.57 |
2024-10-31 | 341.18 | -503.17 | 150.09 |
2024-07-31 | 307.74 | -505.72 | 234.53 |
2024-04-30 | 276.72 | -306.89 | 55.76 |
2024-01-31 | 242.83 | -46.07 | -47.04 |
2023-10-31 | 221.24 | -45.08 | -52.30 |
2023-07-31 | 212.07 | -43.19 | -55.42 |
2023-04-30 | 175.11 | -54.06 | -56.66 |
2023-01-31 | 150.65 | -119.13 | -2.67 |
2022-10-31 | 145.72 | -580.15 | -4.50 |
2022-07-31 | 120.06 | -646.30 | -50.62 |
2022-04-30 | 117.15 | -645.65 | -47.03 |
2022-01-31 | 141.00 | -639.25 | 394.86 |
2021-10-31 | 151.34 | -188.18 | 386.61 |
2021-07-31 | 181.12 | -129.54 | 433.26 |
2021-04-30 | 197.51 | -139.47 | 507.64 |
2021-01-31 | 181.62 | -96.96 | 52.42 |
2020-10-31 | 151.66 | -101.83 | 74.97 |
2020-07-31 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-07-31 | |||
2025-04-30 | |||
2025-01-31 | |||
2024-10-31 | |||
2024-07-31 | |||
2024-04-30 | |||
2024-01-31 | |||
2023-10-31 | |||
2023-07-31 | |||
2023-04-30 | |||
2023-01-31 | |||
2022-10-31 | |||
2022-07-31 | |||
2022-04-30 | |||
2022-01-31 | |||
2021-10-31 | |||
2021-07-31 | |||
2021-04-30 | |||
2021-01-31 | |||
2020-10-31 | |||
2020-07-31 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-07-31 | ||
2025-04-30 | ||
2025-01-31 | ||
2024-10-31 | ||
2024-07-31 | ||
2024-04-30 | ||
2024-01-31 | ||
2023-10-31 | ||
2023-07-31 | ||
2023-04-30 | ||
2023-01-31 | ||
2022-10-31 | ||
2022-07-31 | ||
2022-04-30 | ||
2022-01-31 | ||
2021-10-31 | ||
2021-07-31 | ||
2021-04-30 | ||
2021-01-31 | ||
2020-10-31 | ||
2020-07-31 |
Management Effectiveness
- The roa for HealthEquity, Inc. as of July 31, 2025 is 0.03.
- The roe for HealthEquity, Inc. as of July 31, 2025 is 0.06.
- The roic for HealthEquity, Inc. as of July 31, 2025 is 0.04.
- The croic for HealthEquity, Inc. as of July 31, 2025 is 0.01.
- The ocroic for HealthEquity, Inc. as of July 31, 2025 is 0.10.
Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
2025-07-31 | 0.03 | 0.06 | 0.04 | 0.01 | 0.10 |
2025-04-30 | 0.04 | 0.06 | 0.04 | 0.01 | 0.10 |
2025-01-31 | 0.03 | 0.05 | 0.03 | -0.03 | 0.11 |
2024-10-31 | 0.03 | 0.05 | 0.03 | -0.00 | 0.10 |
2024-07-31 | 0.03 | 0.05 | 0.03 | 0.01 | 0.09 |
2024-04-30 | 0.03 | 0.04 | 0.03 | 0.01 | 0.09 |
2024-01-31 | 0.02 | 0.03 | 0.02 | 0.05 | 0.08 |
2023-10-31 | 0.01 | 0.02 | 0.01 | 0.04 | 0.08 |
2023-07-31 | 0.00 | 0.01 | 0.00 | 0.04 | 0.07 |
2023-04-30 | -0.01 | -0.01 | -0.01 | 0.01 | 0.05 |
2023-01-31 | -0.01 | -0.01 | -0.01 | 0.01 | 0.05 |
2022-10-31 | -0.02 | -0.03 | -0.02 | -0.15 | 0.05 |
2022-07-31 | -0.02 | -0.03 | -0.02 | -0.20 | 0.04 |
2022-04-30 | -0.02 | -0.03 | -0.02 | -0.04 | 0.05 |
2022-01-31 | -0.02 | -0.03 | -0.02 | -0.04 | 0.05 |
2021-10-31 | 0.00 | 0.00 | 0.00 | 0.17 | 0.06 |
2021-07-31 | 0.00 | 0.00 | 0.00 | 0.19 | 0.07 |
2021-04-30 | 0.00 | 0.00 | 0.00 | 0.19 | 0.07 |
2021-01-31 | 0.00 | 0.00 | 0.00 | 0.05 | 0.06 |
2020-10-31 | -0.02 | -0.02 | -0.01 | -0.22 | 0.05 |
2020-07-31 | -0.02 | -0.02 | -0.01 | -0.22 | 0.05 |
Gross Margins
- The gross margin for HealthEquity, Inc. as of July 31, 2025 is 0.66.
- The net margin for HealthEquity, Inc. as of July 31, 2025 is 0.10.
- The operating margin for HealthEquity, Inc. as of July 31, 2025 is 0.20.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
2025-07-31 | 0.66 | 0.10 | 0.20 |
2025-04-30 | 0.66 | 0.10 | 0.20 |
2025-01-31 | 0.65 | 0.08 | 0.17 |
2024-10-31 | 0.65 | 0.08 | 0.17 |
2024-07-31 | 0.65 | 0.10 | 0.16 |
2024-04-30 | 0.63 | 0.08 | 0.14 |
2024-01-31 | 0.62 | 0.06 | 0.13 |
2023-10-31 | 0.61 | 0.03 | 0.11 |
2023-07-31 | 0.60 | 0.01 | 0.09 |
2023-04-30 | 0.57 | -0.03 | 0.04 |
2023-01-31 | 0.57 | -0.03 | 0.04 |
2022-10-31 | 0.55 | -0.07 | 0.02 |
2022-07-31 | 0.55 | -0.07 | 0.04 |
2022-04-30 | 0.56 | -0.06 | 0.05 |
2022-01-31 | 0.56 | -0.06 | 0.05 |
2021-10-31 | 0.57 | 0.00 | 0.08 |
2021-07-31 | 0.56 | 0.01 | 0.09 |
2021-04-30 | 0.56 | 0.01 | 0.09 |
2021-01-31 | 0.57 | 0.00 | 0.14 |
2020-10-31 | 0.58 | -0.03 | 0.14 |
2020-07-31 | 0.58 | -0.03 | 0.14 |
Identifiers and Descriptors
Central Index Key (CIK) | 1428336 |
Industry Groups
SIC 7389 - Business Services, Not Elsewhere Classified |